Literature DB >> 1575942

Increased plasma levels of endothelin in diabetic patients with hypertension.

T Haak1, E Jungmann, A Felber, U Hillmann, K H Usadel.   

Abstract

In order to gain insight into the potential role of endothelin, a 21 amino acid peptide produced by endothelial cells, in the development of complications of diabetes mellitus, basal plasma endothelin levels were measured in 152 patients with diabetes mellitus (83 patients with type 1 diabetes mellitus, 69 patients with type 2 diabetes mellitus) and compared to those in 50 healthy controls. Blood was drawn at 8:00 AM under resting conditions and endothelin was measured after prior extraction by a sensitive radioimmunoassay specific for both endothelin 1 and 2. Endothelin levels were increased in patients with diabetes mellitus in comparison to controls. In type 1 diabetes mellitus a positive correlation between endothelin levels and age was found. We found that 60% of patients with type 1 diabetes mellitus and elevated endothelin levels higher than 2.5 pg/mL (highest value in a control person) had had diabetes for more than 20 years (P less than .05 v patients with normal endothelin levels). In type 2 diabetes mellitus the relation between elevated endothelin levels and diabetes duration was reversed. Glycosylated hemoglobin (HbA1) concentrations above 10% of total hemoglobin were measured in 62% of the patients. Arterial hypertension was present in 60% of the patients with type 1 diabetes mellitus and increased endothelin levels greater than 2.5 pg/mL (both P less than .05 v patients with normal endothelin levels).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1575942     DOI: 10.1093/ajh/5.3.161

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  20 in total

1.  Endothelin-1-mediated cerebrovascular remodeling is not associated with increased ischemic brain injury in diabetes.

Authors:  Weiguo Li; Aisha I Kelly-Cobbs; Erin M Mezzetti; Susan C Fagan; Adviye Ergul
Journal:  Can J Physiol Pharmacol       Date:  2010-08       Impact factor: 2.273

Review 2.  Role of endothelin in diabetic vascular complications.

Authors:  H C Lam
Journal:  Endocrine       Date:  2001-04       Impact factor: 3.633

3.  Dual endothelin receptor antagonism prevents remodeling of resistance arteries in diabetes.

Authors:  Kamakshi Sachidanandam; Vera Portik-Dobos; Aisha I Kelly-Cobbs; Adviye Ergul
Journal:  Can J Physiol Pharmacol       Date:  2010-06       Impact factor: 2.273

4.  Endothelin-1 stimulates insulin secretion by direct action on the islets of Langerhans in mice.

Authors:  S Gregersen; J L Thomsen; B Brock; K Hermansen
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

5.  Impact of glycaemic control on urinary albumin excretion in patients with type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  E Jungmann; C Carlberg; P M Schumm-Draeger
Journal:  Diabetologia       Date:  1994-04       Impact factor: 10.122

Review 6.  Endothelin and its antagonists in hypertension: can we foresee the future?

Authors:  P Moreau; T J Rabelink
Journal:  Curr Hypertens Rep       Date:  1999 Feb-Mar       Impact factor: 5.369

7.  Dysregulated aldosterone secretion in persons of African descent with endothelin-1 gene variants.

Authors:  Jia W Tan; Tina Gupta; Worapaka Manosroi; Tham M Yao; Paul N Hopkins; Jonathan S Williams; Gail K Adler; Jose R Romero; Gordon H Williams
Journal:  JCI Insight       Date:  2017-12-07

Review 8.  Role of microangiopathy in diabetic cardiomyopathy.

Authors:  Adriana Adameova; Naranjan S Dhalla
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

9.  Human atrial natriuretic peptide in patients with type 1 diabetes mellitus: is it related to the development of diabetic nephropathy?

Authors:  E Jungmann; A Felber; S Graeber; U Hillmann; T Haak; K D Palitzsch; K H Usadel
Journal:  Clin Investig       Date:  1993-08

Review 10.  Twenty years after ACEIs and ARBs: emerging treatment strategies for diabetic nephropathy.

Authors:  Stacy A Johnson; Robert F Spurney
Journal:  Am J Physiol Renal Physiol       Date:  2015-09-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.